title: Vaccine Adjuvants Confer an Advantage to the Kinetics of Activation of Follicular Dendritic Cells that are Sensitive to Peripheral Tissue's Injury.
authors.affiliation: Novartis Vaccines and Diagnostics, GSK company, Siena, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Cantisani
authors.affiliation: Novartis Vaccines and Diagnostics, GSK company, Siena, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Piccioli
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D020566:Dendritic Cells, Follicular / Q000276:immunology*; D006801:Humans; D051379:Mice; D011136:Polysorbates; D017452:Receptors, IgG / Q000096:biosynthesis; D013185:Squalene / Q000276:immunology*; D014612:Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; C499172:Fcgr2b protein, mouse; C485700:Fcgr3 protein, mouse; C089950:MF59 oil emulsion; D011136:Polysorbates; D017452:Receptors, IgG; D014612:Vaccines; D013185:Squalene